increased glutathione in acute myeloid leukemia Metabolic reprogramming and immune regulation α-Ketoglutarate dehydrogenase is a therapeutic
Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia ScienceDirect Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells ScienceDirect ABCC1 and glutathione metabolism limit the efficacy of BCL 2 inhibitors in acute myeloid leukemia Nature Communications Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response Leukemia Primary human AML cells have aberrant glutathione metabolism. Amount of Download Scientific Diagram
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3




